Search Results 1381-1390 of 18149 for monoclonal antibody

1. Publications - Paschalis Vergidis, M.D., M.S. - Mayo Clinic

   Serial Evaluation of Preimmunization Antibody Titers in Lymphoma Patients ... A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to ...

2. Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma - Mayo Clinic

   Received any prior monoclonal antibody against CTLA-4, programmed cell death 1 (PD1) or programmed cell death 1 ligand 1 (PD-L1);; History of chronic ...

3. A Phase 1-2 Multi-Center Study Evaluating Axicabtagene Ciloleucel In Subjects With Refractory Aggressive Non-Hodgkin Lymphoma (ZUMA-1) - Mayo Clinic

   anti-CD20 monoclonal antibody unless investigator determines that tumor is CD20 negative, and; an anthracycline containing chemotherapy regimen;; for subjects ...

4. A Study to Evaluate VSV-hIFNbeta-NIS to Treat Patients with Relapsed/Refractory Multiple Myleoma, Acute Myeloid Leukemia, or T-cell Lymphoma - Mayo Clinic

   - Immunotherapy (monoclonal antibodies) =< 4 weeks prior to registration - Experimental agent in case of AML or TCL within 4 half-lives of the last dose of

5. Project 1: Targeting Resistance to T Cell-Directed Therapy in Multiple Myeloma - Mayo Clinic Research

   Both chimeric antigen receptor (CAR)-T cell and bispecific antibody (BsAb) as T cell-directed therapies have yielded impressive clinical responses in people ...

6. A Study To Evaluate The Effectiveness, Safety And Tolerability Of Efgatigimod PH20 SC In Adults With Pemphigus - Mayo Clinic

   Use of any monoclonal antibody (including rituximab or another anti-CD20 biologic) within 6 months before the baseline visit. Known hypersensitivity to any ...

7. Ofatumumab As Primary Therapy Of Chronic Graft Versus Host Disease - Mayo Clinic

   Prior treatment with anti-CD20 monoclonal antibody or alemtuzumab within 3 months prior to start of therapy. Uncontrolled infectious complications not ...

8. Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) - Mayo Clinic

   Prior anti-cancer monoclonal antibody (mAb) within 4 weeks prior to study Day 1 or not recovered from an adverse event caused by mAbs administered more than 4 ...

9. Clinical trials - Oncology (Medical)

   The purpose of this study is to assess the feasibility and develop procedures for detecting monoclonal proteins via finger pick blood spots and saliva. Data ...

10. A Study of Pembrolizumab Alone or Combined with CC-486 for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer - Mayo Clinic

    Prior treatment with a monoclonal antibody within 4 weeks prior to ... Known or suspected hypersensitivity to monoclonal antibodies; Currently ...